| | | | | | | | | | | | | | | | |
| |
 | Issue Date FY: 2025 ( Subtotal = $2,161,929 ) |
| 2025 | 2025 | SYNTIS BIO INC | 135 MORRISSEY BLVD | BOSTON | MA | 02125-3310 | SUFFOLK | USA | R44DK138869 | Polymer Epithelial Lining for the Oral Delivery of Macromolecules | 004 | 2 | NIH | 5/28/2025 | $1,245,529 |
| 2025 | 2025 | SYNTIS BIO INC | 135 MORRISSEY BLVD | BOSTON | MA | 02125-3310 | SUFFOLK | USA | R44DK141341 | Development of an Oral Pill to Mimic the Effects of Gastric Bypass Surgery | 002 | 2 | NIH | 7/2/2025 | $916,400 |
| 2025 | 2024 | SYNTIS BIO INC | 135 MORRISSEY BLVD | BOSTON | MA | 02125-3310 | SUFFOLK | USA | R44DK138869 | Polymer Epithelial Lining for the Oral Delivery of Macromolecules | 002 | 1 | NIH | 12/20/2024 | $0 |
| 2025 | 2024 | SYNTIS BIO INC | 135 MORRISSEY BLVD | BOSTON | MA | 02125-3310 | SUFFOLK | USA | R44DK141341 | Development of an Oral Pill to Mimic the Effects of Gastric Bypass Surgery | 001 | 1 | NIH | 12/4/2024 | $0 |
| 2025 | 2024 | SYNTIS BIO INC | 135 MORRISSEY BLVD | BOSTON | MA | 02125-3310 | SUFFOLK | USA | R44DK141341 | Development of an Oral Pill to Mimic the Effects of Gastric Bypass Surgery | 000 | 1 | NIH | 10/18/2024 | $0 |
| 2025 | 2024 | SYNTIS BIO INC | 135 MORRISSEY BLVD | BOSTON | MA | 02125-3310 | SUFFOLK | USA | R44DK138869 | Polymer Epithelial Lining for the Oral Delivery of Macromolecules | 003 | 1 | NIH | 5/8/2025 | $0 |
| 2025 | 2024 | SYNTIS BIO INC | 135 MORRISSEY BLVD | BOSTON | MA | 02125-3310 | SUFFOLK | USA | R44DK138869 | Polymer Epithelial Lining for the Oral Delivery of Macromolecules | 001 | 1 | NIH | 11/6/2024 | $0 |
| 2025 | 2024 | SYNTIS BIO INC | 135 MORRISSEY BLVD | BOSTON | MA | 02125-3310 | SUFFOLK | USA | R44DK138869 | Polymer Epithelial Lining for the Oral Delivery of Macromolecules | 000 | 1 | NIH | 10/28/2024 | $0 |
|
 | Issue Date FY: 2024 ( Subtotal = $671,947 ) |
| 2024 | 2024 | SYNTIS BIO INC | 69 RICHMOND ST | DORCHESTER | MA | 02124-5729 | SUFFOLK | USA | R44DK138869 | Polymer Epithelial Lining for the Oral Delivery of Macromolecules | 000 | 1 | NIH | 4/24/2024 | $349,160 |
| 2024 | 2024 | SYNTIS BIO INC | 135 MORRISSEY BLVD | BOSTON | MA | 02125-3310 | SUFFOLK | USA | R44DK141341 | Development of an Oral Pill to Mimic the Effects of Gastric Bypass Surgery | 000 | 1 | NIH | 9/12/2024 | $322,787 |
|
|